HistoSonics Appoints Mike Blue as CEO and Board Member; Completes First Close of a Series B Financing 03/13/2017 ANN ARBOR, Mich., March 13, 2017 /PRNewswire/ — HistoSonics, Inc. announced today that Mike Blue has joined the Company as President, CEO and Board member to lead the advancement of HistoSonics’ innovative tissue-destruction technology in liver cancer and other solid tumor applications. HistoSonics’ […]
